Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, January 20, 2025.
Range Cancer Therapeutics ETF (NASDAQ:CNCR)
Long-Term Downtrend (-90) - CNCR is in a strong downtrend that is likely to continue. While CNCR is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CNCR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CNCR
The long-term trend has been DOWN since Nov 21st, 2024 at 13.110
The intermediate-term trend has been DOWN since Jan 13th, 2025 at 11.910
The short-term trend has been DOWN since Jan 8th, 2025 at 12.802
Smart Scan Analysis for CNCR
Based on our trend formula, CNCR is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 11.74 | 11.70 | 11.65 | 11.65 | -0.03 |
| Prev. Close | Volume | Bid | Ask | Time |
| 11.67 | 302 | 2025-01-16 10:33:57 |
| Year High | 32.32 | Year High Date | 2018-03-13 |
| Year Low | 19.1252 | Year Low Date | 2018-10-29 |
| 52wk High | 17.9599 | 52wk High Date | 2024-03-01 |
| 52wk Low | 11.38 | 52wk Low Date | 2025-01-14 |
| Average Volume | 4,242 | Shares Outstanding | 100 |
| Market Cap | 34M | Volatility | 39.81 |